Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice: Final analysis from the prospective, observational CORRELATE study
Ducreux, M., Petersen, L., Öhler, L., Bergamo, F., Metges, J., de Groot, J., Wang, J., García Paredes, B., Kumar, N., Fiala-Buskies, S., Cervantes, A., O’Connor, J., Falcone, A.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Real-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
O'Connor, J M, Ducreux, M, Petersen, L N, Öhler, L, Bergamo, F, Metges, J-P, de Groot, J W, Wang, J-Y, García Paredes, B, Dochy, E, Fiala-Buskies, S, Cervantes, A, Falcone, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study
Yeh, K.-H., Yang, T.-S., Hsu, T.-C., Chen, W.T.-L., Chen, H.-H., Teng, H.-W., Lin, B.-W., Kuan, F.-C., Chiang, F.-F., Duann, C.-W., Li, Y.-S., Fiala-Buskies, S., Ducreux, M., Wang, J.-Y.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer
Vjaters, E., Fizazi, K., James, N.D., Tammela, T.L., Matsubara, N., Priou, F., Beuzeboc, P., Lesimple, T., Bono, P., Kataja, V., Garcia, J.A., Protheroe, A., Aspegren, J., Joensuu, H., Kuss, I., Thiele, S., Fiala-Buskies, S., Jones, R.H.
Published in European urology (01.02.2022)
Published in European urology (01.02.2022)
Get full text
Journal Article
Exploration of efficacious alternative regorafenib regimens to manage hand-foot-skin-reaction (HFSR)
Grothey, A., Hoefman, S., Ruppert, M., Vis, P., Zisowsky, J., Fiala-Buskies, S., Van Cutsem, E., Dochy, E., Cleton, A., Ploeger, B.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
658P - Exploration of efficacious alternative regorafenib regimens to manage hand-foot-skin-reaction (HFSR)
Grothey, A., Hoefman, S., Ruppert, M., Vis, P., Zisowsky, J., Fiala-Buskies, S., Van Cutsem, E., Dochy, E., Cleton, A., Ploeger, B.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
658PExploration of efficacious alternative regorafenib regimens to manage hand-foot-skin-reaction (HFSR)
Grothey, A, Hoefman, S, Ruppert, M, Vis, P, Zisowsky, J, Fiala-Buskies, S, Van Cutsem, E, Dochy, E, Cleton, A, Ploeger, B A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study
Merle, P., Lim, H.Y., Finn, R.S., Ikeda, M., Kudo, M., Frenette, C., Masi, G., Kim, Y.J., Gerolami, R., Kurosaki, M., Numata, K., Klümpen, H-J., Zebger-Gong, H., Fiala-Buskies, S., Ozgurdal, K., Qin, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
173P Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study
Lim, H.Y., Kim, Y.J., Huang, Y-H., Shao, G., Kim, D.Y., Cho, S.B., Hsu, C-H., Lin, S-M., Jeng, L-B., Kuo, K-K., Mao, Y., Zhu, K., Hong, Y.M., Lee, H.C., Ryoo, B-Y., Niu, Z., Wu, L., Fiala-Buskies, S., Kapur, S., Qin, S.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
THU-067 - Correlation of efficacy and safety outcomes with regorafenib exposure in patients with hepatocellular carcinoma
Cleton, A., Graudenz, K., Huang, F., Fiala-Buskies, S., Ploeger, B., Schlief, S., Bonata, P., Meinhardt, G.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
1009P Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study
Lim, H.Y., Kim, Y.J., Huang, Y-H., Shao, G., Kim, D.Y., Cho, S.B., Hsu, C-H., Lin, S-M., Jeng, L-B., Kuo, K-K., Mao, Y., Zhu, K., Hong, Y.M., Lee, H.C., Ryoo, B-Y., Niu, Z., Wu, L., Fiala-Buskies, S., Kapur, S., Qin, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
O'Connor, J M, Ducreux, M, Petersen, L N, Öhler, L, Bergamo, F, Metges, J-P, de Groot, J W, Wang, J-Y, García Paredes, B, Dochy, E, Fiala-Buskies, S, Cervantes, A, Falcone, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
O-012Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice: Final analysis from the prospective, observational CORRELATE study
Ducreux, M, Petersen, L, Öhler, L, Bergamo, F, Metges, J, de Groot, J, Wang, J, García Paredes, B, Kumar, N, Fiala-Buskies, S, Cervantes, A, O'Connor, J, Falcone, A
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
109PReal-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study
Yeh, K-H, Yang, T-S, Hsu, T-C, Chen, W T-L, Chen, H-H, Teng6, H-W, Lin, B-W, Kuan, F-C, Chiang, F-F, Duann, C-W, Li, Y-S, Fiala-Buskies, S, Ducreux, M, Wang, J-Y
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article